Sevincio Tablet, commonly referred to as Sevincio Tablet 10's, is a medication classified as a phosphate binder, designed to reduce high phosphate levels in the body, a condition known as hyperphosphataemia. It is primarily prescribed for adult patients undergoing dialysis, whether through standard dialysis or hemodialysis, and for individuals with chronic kidney disease. The active ingredient in Sevincio Tablet 10's is sevelamer, which functions by binding phosphate in the gastrointestinal tract to limit absorption. This action effectively lowers phosphate levels in the blood, preventing the dangerous accumulation of phosphate, supporting bone health, and reducing the risk of heart disease and strokes.
When taking Sevincio Tablet 10's, it is crucial to adhere to the dosage and schedule recommended by your healthcare provider. It is advised to consume the tablet with food consistently at the same time each day to achieve optimal therapeutic outcomes. However, like any medication, Sevincio Tablet 10's may induce side effects such as vomiting, abdominal pain, nausea, diarrhea, stomach discomfort, indigestion, and flatulence. Should these side effects persist or worsen, it is essential to seek guidance from your doctor promptly.
Patients considering Sevincio Tablet 10's should be cautious if they have a history of allergies to any ingredients in the medication, low phosphate levels in the blood, or bowel obstruction. Notably, Sevincio Tablet 10's contains lactose; thus, individuals with sugar intolerances should consult their healthcare provider before commencement. Additionally, it is crucial to inform your doctor if you encounter difficulties swallowing, experience gastrointestinal motility issues, have a history of frequent vomiting, are post-major stomach or bowel surgery, or suffer from inflammatory bowel conditions before starting the medication.
For individuals with long-term kidney disease necessitating dialysis, SEVINCIO 400 TABLET provides another treatment option targeting serum phosphate levels. This medication, also containing sevelamer, falls under the category of Phosphate Binding Agents and is specifically recommended for renal failure patients experiencing elevated phosphorous levels due to compromised phosphate filtration by the kidneys. During SEVINCIO 400 TABLET therapy, periodic testing may be required to monitor potential side effects and dietary modifications as per your doctor's instructions.
SEVINCIO 400 TABLET should be used cautiously in patients with swallowing difficulties, motility challenges in the gastrointestinal tract, or a history of extensive bowel surgeries. Pregnant individuals should only take SEVINCIO 400 TABLET under clear medical necessity, and breastfeeding mothers should consult their healthcare provider before use due to potential impacts on the infant. This medication is not intended for use in children and adolescents below 18 years of age.
Common side effects associated with SEVINCIO 400 TABLET include constipation, vomiting, abdominal pain, nausea, diarrhea, indigestion, and flatulence. Consult your doctor if any of these side effects worsen or fail to improve during treatment with SEVINCIO 400 TABLET.
